Immature Reticulocyte Fraction (IRF): Clinical Utility in Medical Practice
{"Image DocumentName": "Immature Reticulocyte Fraction (IRF): Clinical Utility in Medical Practice", "Image ImageDescription": "Monitor BM or Stem Cell Regeneration post-BMT or ChemoRx. Monitor Renal Transplant Engraftment (Epo production) Monitor Neonatal Transfusion Needs. Monitor Anemia Therapy. Monitor EPO Therapy: Renal Failure, AIDS, Infants, MDS. Monitor Bone Marrow Toxic Insults from drugs (eg. AZT) Prognostic in Anemia of AIDS and Prematurity. Timing for Stem Cell Harvests following Growth Factor or Cytotoxic Drug Therapy. Detection of Aplastic Crisis in Hemolytic Anemias. Diagnosis and monitoring of aplastic anemia. Evaluate Normochromic Anemias of Various Etiologies. Detection of Occult or Compensated Hemorrhage or Hemolysis. Classification of Anemias.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}